Furthermore, the investigation of the distribution of median ApoA-I levels among various clinicopathological characteristics revealed notably lower ApoA-I levels in male patients with stage III–IV CRC, patients who experienced recurrence, and patients who died (Figure S2). The gene discussed is APOA1; the disease is colorectal carcinoma.